Zaleplon Capsule
Product Images NDC 68788-8725

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Zaleplon (NDC 68788-8725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (Zaleplon Capsules Figure 1)

Chemical structure of Zaleplon, showing the molecular arrangement of atoms and bonds characteristic of this active ingredient.*

FDA Label Image

Zaleplon Cap Usp 10mg (Zaleplon Capsules Figure 3)

Label for Zaleplon Capsules USP 10 mg (CIV), a human prescription drug by Preferred Pharmaceuticals Inc. The label includes dosing directions in English and Spanish with spaces to fill in tablets and frequency. It states the product is generic for Sonata, manufactured by OrBion Pharmaceuticals Pvt. Ltd. Storage instructions and a caution regarding federal law are also visible. The capsule is described as green and blue with imprint ZLP 2130.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.